Skip to Content

LP 609 (Temozolomide 250 mg)

Pill with imprint LP 609 is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Lotus Pharmaceutical Co., Ltd..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LP 609

Temozolomide

Imprint
LP 609
Strength
250 mg
Color
White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lotus Pharmaceutical Co., Ltd.
National Drug Code (NDC)
40051-0609
Inactive Ingredients
lactose anhydrous, silicon dioxide, sodium starch glycolate type A corn, tartaric acid, stearic acid, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.